Stock Information
Regeneron Pharmaceuticals Inc (REGN)
Ticker Symbol: REGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $80,070.03 mil
Piotroski score: 5
PE Ratio: 16.453
EPS (TTM): 41.5481
Revenue (TTM): $133.17 M
Dividend Yield: 0.53177948123214%
ROE: 14.83%
Latest News
-
Regeneron Pharmaceuticals : Q1 2026 Earnings Conference Call Transcript
Fri, May 1, 2026 3:29 PM
-
Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Friday
Fri, May 1, 2026 3:10 PM
-
Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $995
Fri, May 1, 2026 11:41 AM
-
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
Fri, May 1, 2026 10:51 AM
-
Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown — For Now
Thu, Apr 30, 2026 8:21 PM
-
Regeneron's Eylea Franchise on 'Solid Footing' Despite HD Sales Miss in Q1, Oppenheimer Says
Thu, Apr 30, 2026 5:57 PM
-
Eli Lilly is firing on all cylinders, says BMO's Evan Seigerman
Thu, Apr 30, 2026 3:05 PM
-
RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Lowers Price Target to $762
Thu, Apr 30, 2026 1:12 PM
-
Regeneron Pharmaceuticals Analysts Cut Their Forecasts Following Q1 Earnings
Thu, Apr 30, 2026 12:36 PM
-
Barclays Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $917
Thu, Apr 30, 2026 11:50 AM
Key Financials
Financial data not available
